Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Roche has been leading research into the HER2 pathway for over 30 years and is committed to improving the health, quality of ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...